JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the launch of the Authorized Generic of Detrol®* LA (tolterodine tartrate extended-release capsules) 2 mg and 4 mg in the U.S. market. Detrol® LA had annual sales of approximately $571.5 million in the U.S., according to IMS data as of September 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
